drugset / Trial / NCT01408394
Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam
RandomizedCrossoverSingle-blindTreatment
Summary
Ecopipam hydrochloride (HCl) is an investigational drug being studied for several possible diseases. To date, all clinical studies have been done using the ecopipam immediate release (IR) tablet. However, a controlled release (CR) capsule formulation of ecopipam has been produced that may be able to improve its effectiveness and reduce its side effects. The main purpose of this study is to evaluate the safety and tolerability of ecopipam CR capsules when given as single oral dose in healthy volunteers.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-02
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ecopipam | Small molecule | 90 mg | Oral |
| Comparator | Ecopipam | Small molecule | 100 mg | Oral |
| Comparator | Ecopipam | Small molecule | 180 mg | Oral |
Indications
No indication recorded.